Marc A Pfeffer
Overview
Explore the profile of Marc A Pfeffer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
500
Citations
28799
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu H, Kondo T, Claggett B, Vaduganathan M, Neuen B, Beldhuis I, et al.
J Am Coll Cardiol
. 2025 Jan;
85(7):710-722.
PMID: 39745404
Background: Hypertension is common in patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), and current guidelines recommend treating systolic blood pressure (SBP) to a target <130 ...
2.
Lu H, Inciardi R, Abanda M, Shah A, cikes M, Claggett B, et al.
J Am Heart Assoc
. 2024 Dec;
14(1):e037380.
PMID: 39719412
Background: This study aims to characterize right ventricular dysfunction (RVD) in heart failure (HF) with preserved ejection fraction and understand the cumulative prognostic value of abnormal RV echocardiographic parameters in...
3.
Foa A, Pabon M, Braunwald E, Jering K, Vaduganathan M, Claggett B, et al.
Eur J Heart Fail
. 2024 Dec;
PMID: 39694540
Aims: The temporal changes in clinical profiles and outcomes of high-risk myocardial infarction survivors enrolled in clinical trials are poorly described. This study compares mortality rates, baseline characteristics, and the...
4.
Amir O, Elbaz-Greener G, Carasso S, Claggett B, Barbarash O, Zaman A, et al.
Eur J Heart Fail
. 2024 Dec;
PMID: 39692068
Aims: The relationship between body mass index (BMI) and clinical outcomes in patients with cardiovascular disease, including acute heart failure (AHF) and acute myocardial infarction (AMI), remains debated. This study...
5.
Wang X, Vardeny O, Claggett B, Vaduganathan M, Hegde S, Skali H, et al.
Eur J Heart Fail
. 2024 Dec;
27(1):96-106.
PMID: 39675788
Aims: To evaluate clinical outcomes, echocardiographic features, and the efficacy and safety of sacubitril/valsartan compared to valsartan across age groups in the PARAGON-HF trial. Methods And Results: A total of...
6.
Mc Causland F, Vaduganathan M, Claggett B, Gori M, Jhund P, McGrath M, et al.
JACC Heart Fail
. 2024 Nov;
13(1):105-114.
PMID: 39570234
Background: Lower estimated glomerular filtration rate (eGFR) may be one of the major reasons for hesitation or failure to initiate potentially beneficial therapies in patients with heart failure (HF). Objectives:...
7.
8.
Marti-Castellote P, Reeder C, Claggett B, Claggett B, Singh P, Lau E, et al.
Circ Heart Fail
. 2024 Nov;
18(1):e012514.
PMID: 39549261
Background: Medical record review by a physician clinical events committee is the gold standard for identifying cardiovascular outcomes in clinical trials, but is labor-intensive and poorly reproducible. Automated outcome adjudication...
9.
Wandel S, Desai A, Chen C, McMurray J, Packer M, Solomon S, et al.
Eur Heart J
. 2024 Nov;
45(47):5087-5099.
PMID: 39515836
Background And Aims: Heart failure endpoints in cardiovascular outcome trials are commonly identified through centralized adjudication of investigator-reported events. It remains unclear whether central adjudication improves the accuracy of treatment...
10.
Lu H, Claggett B, Packer M, Pfeffer M, Swedberg K, Rouleau J, et al.
Eur J Heart Fail
. 2024 Oct;
27(1):60-68.
PMID: 39439294
Aims: Resting heart rate (HR) is a strong risk marker in patients with heart failure (HF), but the clinical implications of visit-to-visit changes in HR (ΔHR) are less well established....